Biomerieux Inc 2026-02-11 Health serious FDA
Health · FDA · Recall #FDA-Z-1236-2026
VITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n)… Recall
Issued February 11, 2026 · Biomerieux Inc
In February 2026, Biomerieux Inc recalled the VITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n)…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Potential risk of Quality Control failures and/or false resistant antibiotic results when testing isolates of Enterobacterales/Enterobacteriaceae species and/or Pseudomonas aeruginosa with the identified antibiotic formulations. Issue may lead to QC failure or false resistant results.
What you should do
- 1 Stop using VITEK 2 Gram-negative Susceptibility Cards Containing o Polymyxin B (pb02n)… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Biomerieux Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Biomerieux Inc
- Category
- Health
- Recall date
- February 11, 2026
- Units affected
- Not reported
- Sold at
- Worldwide - US Nationwide distribution.
- Recall number
- FDA-Z-1236-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Biomerieux Inc has 17 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 356th Health recall we've logged in 2026.